Prevalence and risk factors associated with peripheral artery disease in elderly patients undergoing peritoneal dialysis
Ding-Wei Kuang,1,2,* Chiu-Leong Li,1,* Un-I Kuok,1 Kin Cheung,1 Weng-In Lio,1 Jing Xin1,2
1Department of Nephrology, Centro Hospitalar Conde de São Januário, Macao, China; 2Department of Nephrology, Huashan Hospital, Shanghai, China
*These authors contributed equally to this work
Background: Rapid growth of the elderly peritoneal dialysis (PD) population is posing a special challenge for renal teams. Peripheral artery disease (PAD) has been reported to be an independent predictor of cardiovascular and all-cause mortality in hemodialysis patients. However, the prevalence and associated risk factors for PAD in elderly PD patients have not yet been fully investigated.
Methods: A total of 69 elderly PD patients were included in the present study. PAD was defined as either an ankle-brachial index < 0.9 or a history of intermittent claudication, lower-limb amputation, foot ulcers, or gangrene. On enrollment, clinical and biochemical characteristics were collected.
Results: The overall prevalence of PAD was 31.9%. Compared with non-PAD patients, PAD patients were significantly older and more likely to be female and have longer PD duration and lower diastolic blood pressure (P < 0.001, = 0.002, 0.018, and 0.007, respectively). Serum albumin level (P < 0.001) and residual renal Kt/V value (P < 0.001) were significantly lower, but the serum C-reactive protein level (P = 0.005) was significantly higher, in PAD patients compared with non-PAD patients. Logistic regression analysis showed that serum albumin level (odds ratio = 1.485, P = 0.040) and residual renal Kt/V value (odds ratio = 1.725, P = 0.016) were independently associated with PAD.
Conclusion: A high prevalence of PAD appeared among elderly PD patients in Macao. Serum albumin level and residual renal Kt/V value were independently related to PAD.
Keywords: ankle-brachial index, atherosclerosis, elderly, peripheral artery disease, peritoneal dialysis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML]
Readers of this article also read:
Campani V, Marchese D, Pitaro MT, Pitaro M, Grieco P, De Rosa G
Published Date: 10 April 2014
Shi P, Gustafson JA, MacKay JA
Published Date: 26 March 2014
Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier
Chaturvedi M, Molino Y, Sreedhar B, Khrestchatisky M, Kaczmarek L
Published Date: 20 January 2014
Parizek M, Douglas TEL, Novotna K, Kromka A, Brady MA, Renzing A, Voss E, Jarosova M, Palatinus L, Tesarek P, Ryparova P, Lisa V, dos Santos AM, Bacakova L
Published Date: 26 November 2012
Federico C, Morittu VM, Britti D, Trapasso E, Cosco D
Published Date: 1 November 2012
Giorgi MA, Miguel LS
Published Date: 30 August 2012
Titanium dioxide induces apoptotic cell death through reactive oxygen species-mediated Fas upregulation and Bax activation
Yoo KC, Yoon CH, Kwon DW, Hyun KH, Woo SJ, Kim RK, Lim EJ, Suh YJ, Kim MJ, Yoon TH, Lee SJ
Published Date: 5 March 2012
Sun L, Zhao X
Published Date: 2 February 2012
Heidi M Mansour, Yun-Seok Rhee, Xiao Wu
Published Date: 7 December 2009
Rajesh Vasita, Dhirendra S Katti
Published Date: 15 March 2006